Difference between revisions of "Inflammatory Bowel Disease"
Jump to navigation
Jump to search
| (One intermediate revision by one other user not shown) | |||
| Line 3: | Line 3: | ||
==Acceptability at CT / Work-Up== | ==Acceptability at CT / Work-Up== | ||
| − | Discuss each case with Medical Officer. May be acceptable for BM only if only one episode with complete recovery and off immunosuppressive medication for over 1 year. | + | Discuss each case with Medical Officer. |
| + | |||
| + | Not acceptable if total colectomy/bowel resection. | ||
| + | |||
| + | May be acceptable for BM only if only one episode with complete recovery and off immunosuppressive medication for over 1 year. | ||
==Individual at Risk== | ==Individual at Risk== | ||
| Line 20: | Line 24: | ||
==Version== | ==Version== | ||
| − | Version 1, Edition | + | Version 1, Edition 2 |
====Date of Last Update==== | ====Date of Last Update==== | ||
1 June 2016 | 1 June 2016 | ||
Latest revision as of 09:39, 7 January 2026
Contents
Acceptability at Recruitment
NOT ACCEPTABLE
Acceptability at CT / Work-Up
Discuss each case with Medical Officer.
Not acceptable if total colectomy/bowel resection.
May be acceptable for BM only if only one episode with complete recovery and off immunosuppressive medication for over 1 year.
Individual at Risk
Donor / Recipient
Explanation of Condition
Autoimmune condition leading to chronic, relapsing episodes of diarrhoea and bleeding. Treatment includes aspirin-derived medications, steroids and immunosuppression. Severely affected individuals may require surgical removal of parts of the bowel, and there is an increased risk of bowel cancer in sufferers of ulcerative colitis.
Guidance
Discuss with Medical Officer. Risk of donor-acquired autoimmunity in recipient.
Pseudonyms or Related Conditions
Crohns disease
Ulcerative Colitis
Version
Version 1, Edition 2
Date of Last Update
1 June 2016
